Loading...

ACAD ACADIA PHARMACEUTICALS INC Management Changes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2025 8-K

Financial Results Announced

Board Resignation

Financial Statements

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

On October 28, 2025, Daniel B. Soland resigned from the Board of Acadia Pharmaceuticals, effective October 30, 2025; his resignation was not due to any disagreements. This is a significant event for the company.

AI Assistant

ACADIA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.